North America

RIIG Technology Secures $6M+ Series A to Expand AI-Driven Healthcare Automation Platform

Funding will accelerate deployment of AI-powered insurance workflow solutions and support development of scalable healthcare data infrastructure...

Genentech Advances Gazyva® for Lupus with FDA Acceptance of New Application

Regulatory milestone expands potential use of anti-CD20 therapy in lupus, building on prior success in lupus nephritis...

Nexalin Technology Advances FDA Strategy for Alzheimer’s Treatment

The FDA provided clinical guidance on the proposed Alzheimer’s symptom reduction FDA clinical trial and regulatory pathway...

Catheter Precision Secures Shareholder Approval to Acquire Fly Flyte

The acquisition also positions Catheter Precision to participate in the evolving advanced air mobility sector...

Philips Receives Clearance for Verida AI-Powered Detector-Based Spectral CT

Combining always-on spectral imaging with AI reconstruction to deliver enhanced levels of image quality, efficiency, and clinical insight across radiology, cardiology, and oncology...

Stryker Strengthens Peripheral Vascular Strategy With Amplitude Vascular Systems Acquisition

Deal Positions Stryker To Expand Into High Growth Intravascular Lithotripsy Segment And Address Complex Calcified Arterial Disease...

Bracco Secures Health Canada Approval for Vueway® to Advance Lower-Dose MRI Contrast Imaging

Gadopiclenol-based contrast agent enables high-quality imaging at reduced gadolinium exposure, supporting safer diagnostic workflows...

Xodus Medical Secures FDA Clearance for Hot Pink Pad to Improve Surgical Patient Safety

Xodus Medical’s Hot Pink Pad integrates positioning stability and thermal regulation to reduce surgical complications and enhance intraoperative care...

CStone Reveal Preclinical Data on Next-Generation ADCs Targeting EGFR/HER3 and Tumor Heterogeneity

CStone presents preclinical data on three differentiated antibody-drug conjugates, including a dual-target EGFR/HER3 candidate...

Sonire Secures $18Mn Series A to Accelerate HIFU Cancer Treatment Development

Led by Santé, the funding will support completion of the world's first randomised HIFU trial for pancreatic cancer, and accelerate U.S. clinical programs for the company's anaesthesia-free, outpatient sonic therapy...